Nhật chơi sang
Page 1 of 1 • Share
Nhật chơi sang
Anti-influenza Avigan tablets developed by a group firm of Fujifilm Holdings Corp. | AFP-JIJI
Japan might dispense flu drug Avigan to other countries for free as COVID-19 treatment
The government is considering providing Avigan for free to other countries that want to use the flu drug to treat coronavirus patients, Chief Cabinet Secretary Yoshihide Suga said Friday.
“Some 30 countries have made requests through diplomatic channels to Japan for the procurement of Avigan,” Suga said at a news conference. “We’re coordinating to provide the necessary amounts for free to countries wanting it.”
The drug, developed by a group firm of Fujifilm Holdings Corp., is considered effective for treating COVID-19, the disease caused by the virus.
“We intend to expand clinical research on Avigan with countries wishing to cooperate,” the government’s top spokesman said.
Prime Minister Shinzo Abe told a news conference on March 28 that the government will push the development of vaccines and drugs to fight the pneumonia-causing virus.
Fujifilm Toyama Chemical Co. said Tuesday it has begun clinical testing to evaluate the efficacy of Avigan, which is also known as Favipiravir, for treating COVID-19.
On Thursday, the German health ministry said it will seek to purchase Avigan tablets for that purpose. Local media said it will buy several million for patients with severe symptoms.
A study by researchers at Wuhan University and other institutions in China has shown cases in which Avigan was effective against the new coronavirus, especially for those with mild symptoms.
Avigan was manufactured and stocked in Japan as an influenza drug. There is hope it can eventually be used to help treat tick-borne illnesses as well as other diseases, including Ebola.
Japan might dispense flu drug Avigan to other countries for free as COVID-19 treatment
The government is considering providing Avigan for free to other countries that want to use the flu drug to treat coronavirus patients, Chief Cabinet Secretary Yoshihide Suga said Friday.
“Some 30 countries have made requests through diplomatic channels to Japan for the procurement of Avigan,” Suga said at a news conference. “We’re coordinating to provide the necessary amounts for free to countries wanting it.”
The drug, developed by a group firm of Fujifilm Holdings Corp., is considered effective for treating COVID-19, the disease caused by the virus.
“We intend to expand clinical research on Avigan with countries wishing to cooperate,” the government’s top spokesman said.
Prime Minister Shinzo Abe told a news conference on March 28 that the government will push the development of vaccines and drugs to fight the pneumonia-causing virus.
Fujifilm Toyama Chemical Co. said Tuesday it has begun clinical testing to evaluate the efficacy of Avigan, which is also known as Favipiravir, for treating COVID-19.
On Thursday, the German health ministry said it will seek to purchase Avigan tablets for that purpose. Local media said it will buy several million for patients with severe symptoms.
A study by researchers at Wuhan University and other institutions in China has shown cases in which Avigan was effective against the new coronavirus, especially for those with mild symptoms.
Avigan was manufactured and stocked in Japan as an influenza drug. There is hope it can eventually be used to help treat tick-borne illnesses as well as other diseases, including Ebola.
_________________
8DonCo
Re: Nhật chơi sang
Wonder how the company Fuji can afford to make the drugs and gives away for free like that.
ga10
Re: Nhật chơi sang
ga10 wrote:Wonder how the company Fuji can afford to make the drugs and gives away for free like that.
chính phủ Nhât support, thật ra giá làm ra viên thuốc đâu có bao nhiêu tiền
_________________
8DonCo
Re: Nhật chơi sang
8DonCo wrote:ga10 wrote:Wonder how the company Fuji can afford to make the drugs and gives away for free like that.
chính phủ Nhât support, thật ra giá làm ra viên thuốc đâu có bao nhiêu tiền
neu vi` long` nhan dao. vayy thi` that la` qua' tot
TuTu
Re: Nhật chơi sang
8DonCo wrote:ga10 wrote:Wonder how the company Fuji can afford to make the drugs and gives away for free like that.
chính phủ Nhât support, thật ra giá làm ra viên thuốc đâu có bao nhiêu tiền
Vậy là chính phủ Nhật sẽ trả tiền cho hang4 Fuji huh? Hy vọng thuốc này chửa được bịnh coronavirus để tụi mình có thể go back with our normal lives.
Tui nấu ăn mệt rồi!
ga10
Re: Nhật chơi sang
chị Gà, mới có mấy tuần mờ ))...mấy tuần này em cũng không có tennis...ghiền...
_________________
Love This Backhand & Backhand Slice
tech
Re: Nhật chơi sang
tech wrote:chị Gà, mới có mấy tuần mờ ))...mấy tuần này em cũng không có tennis...ghiền...
Thường thì weekend tụi này cũng eat out 1-2 bửa và nấu 1 bửa thôi. Hỗm rày nấu ăn trưa và tối liên tục nên mệt rồi.
Hôm nay buổi trưa làm Kimbap và buổi tối thì bánh xèo. Làm có 2 món thôi mà 0 hiểu sao mệt nhoài vì vừa làm lunch xong là bắt tay vào làm bánh xèo luôn!
Gà thấy nấu ăn tốn sức hơn exercises!
ga10
Re: Nhật chơi sang
ga10 wrote:tech wrote:chị Gà, mới có mấy tuần mờ ))...mấy tuần này em cũng không có tennis...ghiền...
Thường thì weekend tụi này cũng eat out 1-2 bửa và nấu 1 bửa thôi. Hỗm rày nấu ăn trưa và tối liên tục nên mệt rồi.
Hôm nay buổi trưa làm Kimbap và buổi tối thì bánh xèo. Làm có 2 món thôi mà 0 hiểu sao mệt nhoài vì vừa làm lunch xong là bắt tay vào làm bánh xèo luôn!
Gà thấy nấu ăn tốn sức hơn exercises!
Ơ nhà buồn xong ăn hoài.....
vietnam4all
Re: Nhật chơi sang
Mỹ cho thử nghiệm thuốc của Nhật
US trial of Japanese flu drug for coronavirus gets green light
The US Food and Drug Administration has given the green light for the country’s first clinical trial of a Japanese flu drug that could be used to treat the coronavirus, according to a report.
Three Massachusetts hospitals were granted approval Tuesday to launch small trials of the antiviral drug favipiravir, a doctor involved in the efforts told the Boston Globe.
The drug, also known by the brand name Avigan, was hailed by Chinese health officials as “clearly effective” when used on 340 patients in trials there that showed reduced recovery time and improved lung function.
The patients given the drug in the Chinese city of Shenzhen tested negative for the virus with a median of four days after becoming positive — much lower than the average of 11 days for those who were not given the medicine, according to the Guardian.
The US trials — which will take place at Massachusetts General Hospital, Brigham and Women’s Hospital, and UMass Memorial Health Care in Worcester — would involve around 50 or 60 patients with COVID-19, the Globe reported.
Researchers would give one group the drug along with care typical for coronavirus patients, while the control group would only receive the normal standard of treatment, sources told the newspaper.
Dr. Keith T. Flaherty of Massachusetts General Hospital said the favipiravir study was among the more promising of around 30 clinical trials considered by the hospital.
US trial of Japanese flu drug for coronavirus gets green light
The US Food and Drug Administration has given the green light for the country’s first clinical trial of a Japanese flu drug that could be used to treat the coronavirus, according to a report.
Three Massachusetts hospitals were granted approval Tuesday to launch small trials of the antiviral drug favipiravir, a doctor involved in the efforts told the Boston Globe.
The drug, also known by the brand name Avigan, was hailed by Chinese health officials as “clearly effective” when used on 340 patients in trials there that showed reduced recovery time and improved lung function.
The patients given the drug in the Chinese city of Shenzhen tested negative for the virus with a median of four days after becoming positive — much lower than the average of 11 days for those who were not given the medicine, according to the Guardian.
The US trials — which will take place at Massachusetts General Hospital, Brigham and Women’s Hospital, and UMass Memorial Health Care in Worcester — would involve around 50 or 60 patients with COVID-19, the Globe reported.
Researchers would give one group the drug along with care typical for coronavirus patients, while the control group would only receive the normal standard of treatment, sources told the newspaper.
Dr. Keith T. Flaherty of Massachusetts General Hospital said the favipiravir study was among the more promising of around 30 clinical trials considered by the hospital.
_________________
8DonCo
Re: Nhật chơi sang
Unass gần nhà Tech 5 phút....bác sỉ GD Tech cũng ở trong Umass..
_________________
Love This Backhand & Backhand Slice
tech
Similar topics
» sáng sớm hỏi chơi
» Làm sáng tỏ thông tin Bet365 lừa đảo người chơi
» Đi Nhật chơi , It 's open
» Ối giời ạ.....kiểu này sang năm sẽ triple chẳng chơi
» Cách chơi bài Blackjack online chi tiết nhất
» Làm sáng tỏ thông tin Bet365 lừa đảo người chơi
» Đi Nhật chơi , It 's open
» Ối giời ạ.....kiểu này sang năm sẽ triple chẳng chơi
» Cách chơi bài Blackjack online chi tiết nhất
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum